0 Items
Select Page

Wesselsbron Virus

Wesselsbron (WSL) virus is an arthropod-borne virus in the genus Flavivirus of the family Flaviviridae that causes Wesselsbron disease in cattle, sheep, goats, camels, pigs, donkeys, horses, ostriches, and wild ruminants (zebras) with occasional incidental spill-over to humans. The detection of human or animal cases is complicated by the non-specific symptoms close to Rift Valley Fever (RVF) in domestic livestock species or Dengue like syndrome in humans. In humans, fever and myalgia are the symptoms reported. Liver degeneration is the most common pathological finding. WSLV has a wide geographic distribution in Africa and is transmitted by mosquitoes in the genus Aedes including A. caballus and A. circumluteolus.

Wesselsbron Virus Background

Wesselsbron disease (WSL) is an acute arthropod-borne flavivirus infection of sheep, cattle, and goats, causing relatively high mortalities in new-born animals and occasional abortion in adults. In humans it causes a non-fatal influenza-like illness.

The first known outbreak was reported in 1955 on a sheep farm in the town of Wesselsbrons in Orange Free State Province, South Africa and WSLV was isolated from the blood of a febrile man and a dead lamb (Weiss et al., 1956; Weyer et al., 2013). Immunohistochemical staining of sections of formalin-fixed liver has been used to confirm the diagnosis of WSL in new-born lambs using polyclonal antibodies against WSL virus (van der Lugt et al., 1995). WSLV has since been isolated from Cape short-eared gerbil in southern Africa and there is serological evidence for circulation in humans since the 1970s, more recently in eastern Senegal with 2 human cases and isolation of the same strain from a black rat (Diagne et al., 2017).

Flavivirus serological relationships are important in determining diagnosis and epidemiology of infections in Africa. No significant antigenic variation has been observed between WSLV, Potiskum (POT) and Yellow fever virus (YFV) viruses in cross-haemagglutination-inhibition (Cross-HI) and cross-complement fixation (Cross-CF) studies. However, differences in antigenicity were observed between these viruses and Uganda S, Banzi and Zika viruses (Baba et al.,1998).  A flavivirus haemagglutination-inhibition (HI) test adopted to the solid-phase immunosorbent technique (SPIT) was used to confirm the high prevalence of IgM in people of younger age groups in Nigeria. Although not as sensitive as the conventional HI test, it was found to be more specific and potentially feasible for the detection of early WSLV infections in flavivirus hyperendemic environments (Baba et al., 1999).

WSLV is one of a number of lesser known mosquito transmitted flaviviruses but highlights the potential of such viruses to emerge (Smith, 2017). Further investigations are needed to understand the life cycle and the impact on public health. Rodents may act as a reservoir and are abundant worldwide; Aedini populations are expanding their range, all of which may suggest WSLV could have a larger distribution than expected.



  • Baba et al. (1998). Antigenic relatedness of selected flaviviruses: study with homologous and heterologous immune mouse ascitic fluids. Rev Inst Med Trop Sao Paulo. 40(6):343-9.
  • Baba et al. (1999). Preliminary studies on the use of solid-phase immunosorbent techniques for the rapid detection of Wesselsbron virus (WSLV) IgM by haemagglutination-inhibition. Comp Immunol Microbiol Infect Dis. 22(1):71-9.
  • Barnard (1997). Antibodies against some viruses of domestic animals in southern African wild animals. Onderstepoort J Vet Res. 64(2):95-110.
  • Diagne et al. (2017). Emergence of Wesselsbron virus among black rat and humans in Eastern Senegal in 2013. One Health. 3:23-28.
  • Smith (2017) Waiting in the wings: The potential of mosquito transmitted flaviviruses to emerge, Critical Reviews in Microbiology, 43:4, 405-422.
  • van der Lugt et al. (1995). The diagnosis of Wesselsbron disease in a new-born lamb by immunohistochemical staining of viral antigen. Onderstepoort J Vet Res. 62(2):143-6.
  • Weiss et al. (1956). Wesselsbron virus—a virus not previously described, associated with abortion in domestic animals. Onderstepoort Vet. J. 27:183–195.
  • Weyer et al. (2013). Human Cases of Wesselsbron Disease, South Africa 2010–2011. Vector-Borne and Zoonotic Diseases. 13 (5): 330–337.

Wesselsbron Virus Antigens

We are pleased to offer a recombinant Wesselsbron virus NS1 protein for research use. This protein has been manufactured by the Native Antigen Company in mammalian cells and can be used as an antigen for R&D studies and vaccine research.


Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Diagnosing HIV in resource-limited settings

In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus's cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California, 5...

Our Product Pipeline

If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

15 + 8 =

Live Customer Feedback

Join our mailing list

* indicates required